NextCure, Inc. (NXTC)

NextCure Statistics

Total Valuation

NextCure has a market cap or net worth of $21.90 million. The enterprise value is -$4.22 million.

Market Cap	21.90M
Enterprise Value	-4.22M

Important Dates

The last earnings date was Thursday, May 7, 2026, after market close.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

NextCure has 3.61 million shares outstanding. The number of shares has increased by 53.00% in one year.

Current Share Class	3.61M
Shares Outstanding	3.61M
Shares Change (YoY)	+53.00%
Shares Change (QoQ)	+31.60%
Owned by Insiders (%)	1.27%
Owned by Institutions (%)	33.66%
Float	2.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.95
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.15.

Current Ratio	4.61
Quick Ratio	4.32
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -132.40% and return on invested capital (ROIC) is -75.98%.

Return on Equity (ROE)	-132.40%
Return on Assets (ROA)	-66.71%
Return on Invested Capital (ROIC)	-75.98%
Return on Capital Employed (ROCE)	-180.46%
Weighted Average Cost of Capital (WACC)	10.28%
Revenue Per Employee	n/a
Profits Per Employee	-$1.37M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.31% in the last 52 weeks. The beta is 1.43, so NextCure's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	+1.31%
50-Day Moving Average	10.26
200-Day Moving Average	9.98
Relative Strength Index (RSI)	29.46
Average Volume (20 Days)	42,062

Short Selling Information

The latest short interest is 72,144, so 2.00% of the outstanding shares have been sold short.

Short Interest	72,144
Short Previous Month	72,008
Short % of Shares Out	2.00%
Short % of Float	3.20%
Short Ratio (days to cover)	1.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.10M
Pretax Income	-54.66M
Net Income	-54.66M
EBITDA	-54.29M
EBIT	-56.10M
Earnings Per Share (EPS)	-$15.32

Balance Sheet

The company has $29.74 million in cash and $3.88 million in debt, with a net cash position of $25.86 million or $7.17 per share.

Cash & Cash Equivalents	29.74M
Total Debt	3.88M
Net Cash	25.86M
Net Cash Per Share	$7.17
Equity (Book Value)	26.72M
Book Value Per Share	7.41
Working Capital	24.85M

Cash Flow

Operating Cash Flow	-49.98M
Capital Expenditures	n/a
Depreciation & Amortization	1.81M
Net Borrowing	n/a
Free Cash Flow	-49.98M
FCF Per Share	-$13.85

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NextCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.00%
Shareholder Yield	-53.00%
Earnings Yield	-252.54%
FCF Yield	-230.91%

Analyst Forecast

The average price target for NextCure is $19.33, which is 218.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.33
Price Target Difference	218.45%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-59.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 14, 2025. It was a reverse split with a ratio of 1:12.

Last Split Date	Jul 14, 2025
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1